Zynex Stock News

Zynex Inc (ZYXI) shares closed today at 1.2% above its 52 week low of $8.37, giving the company a market cap of $294M. The stock is currently down 5.6% year-to-date, down 35.3% over the past 12 months, and up 4379.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 32.3% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -339.6% The company's stock price performance over the past 12 months lags the peer average by 17.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Zynex Inc (ZYXI) shares closed today at 1.2% above its 52 week low of $8.37, giving the company a market cap of $308M. The stock is currently down 1.0% year-to-date, down 31.6% over the past 12 months, and up 4595.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%. Trading Activity Trading volume this week was 32.3% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 9.8% lower than its 5-day moving average, 15.1% lower than its 20-day moving average, and 30.0% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -334.6% The company's stock price performance over the past 12 months lags the peer average by 5.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Expanding Its Product Portfolio in Patient Monitoring

Zynex (NASDAQ:ZYXI) was downgraded by equities researchers at TheStreet from a b- rating to a c+ rating in a note issued to investors on Monday, TheStreetRatingsTable reports. Other research analysts also recently issued reports about the stock. HC Wainwright reiterated a buy rating and set a $22.00 price objective on shares of Zynex in a []

During the last session, Zynex Inc. (NASDAQ:ZYXI)s traded shares were 0.63 million, with the beta value of the company hitting 0.82. At the end of the trading day, the stocks price was $9.79, reflecting an intraday loss of -0.51% or -$0.05. The 52-week high for the ZYXI share is $22.89, that puts it down -133.81 The Time To Buy Zynex Inc. (NASDAQ: ZYXI) Is Now Read More »

CMI Research has released the latest version of its survey report on the Electrotherapy System Market, which includes 100+ market data tables, a pie chart, graphs and figures scattered over pages. The market is currently expanding its footprint. The research

Wall Street analysts forecast that Zynex, Inc. (NASDAQ:ZYXI) will announce sales of $41.29 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Zynex’s earnings. The lowest sales estimate is $40.54 million and the highest is $42.00 million. Zynex posted sales of $25.61 million in the same quarter […] The post Analysts Expect Zynex, Inc. (NASDAQ:ZYXI) Will Post Quarterly Sales of $41.29 Million appeared first on ETF Daily News .

Radnor Capital Management LLC bought a new stake in Zynex, Inc. (NASDAQ:ZYXI) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 11,250 shares of the companys stock, valued at approximately $128,000. Other hedge funds have also added to or reduced their stakes in []

Zynex Inc. (NASDAQ:ZYXI) price on Friday, December 10, fall -8.10% below its previous days close as a downside momentum from buyers pushed the stocks value to $11.23. A look at the stocks price movement, the close in the last trading session was $12.22, moving within a range at $10.95 and $12.39. The beta value (5-Year Zynex Inc. (ZYXI): Is It Worth A Small Bite At $11.23? Read More »

Analysts expect Zynex, Inc. (NASDAQ:ZYXI) to announce $41.29 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Zynexs earnings. The highest sales estimate is $42.00 million and the lowest is $40.54 million. Zynex reported sales of $25.61 million during the same quarter last year, which indicates a []

Juncture Wealth Strategies LLC lowered its stake in shares of Zynex, Inc. (NASDAQ:ZYXI) by 19.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,326 shares of the company’s stock after selling 5,476 shares during the quarter. Juncture Wealth Strategies LLC owned […]

Wall Street brokerages expect Zynex, Inc. (NASDAQ:ZYXI) to announce $0.20 earnings per share for the current quarter, Zacks reports. Four analysts have made estimates for Zynexs earnings, with the lowest EPS estimate coming in at $0.19 and the highest estimate coming in at $0.20. Zynex reported earnings of $0.05 per share during the same quarter []